Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director · President and CEO | November 07, 2024 | November 08, 2024 |
| STRYKER CORPSYK · Entity 369 | Interim ChiefExecutiveOfficer | February 22, 2012 | February 27, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date November 07, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,996 |
Ending reported balance
After 2024-11-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-11-07 · Exercise / conversion · Acquired 30,000 · Balance 34,299 Row 2 · 2024-11-07 · Tax withholding · Disposed 24,303 · Balance 9,996 |
| SARs (Stock Appreciation Rights)SEC Table II · derivative / convertible security · Conversion / exercise price $51.30 · Expires 2025-02-27 | Direct | 118,300 |
Reported balance
After 2024-11-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-11-07 · Exercise / conversion · Disposed 30,000 · Balance 118,300 F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 83,500 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 83,500 |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period.
STRYKER CORP
Report date February 22, 2012 · Filed February 27, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,019 |
Ending reported balance
After 2012-02-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-02-22 · Exercise / conversion · Acquired 15,000 · Balance 38,778 Row 2 · 2012-02-22 · Tax withholding · Disposed 9,759 · Balance 29,019 F1: 9,759 shares were withheld to cover the option cost and applicable taxes. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $26.40 · Expires 2012-04-28 | Direct | 0 |
Reported balance
After 2012-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2012-02-22 · Exercise / conversion · Disposed 15,000 · Balance 0 F2: Employee stock option granted on April 29, 2002 pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy Custodian | 20 |
Reported balance
Holding disclosure · report date 2012-02-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 20 |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 3,199 |
Reported balance
Holding disclosure · report date 2012-02-22 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,199 |
Filing footnotes · ownership attribution and instrument terms
F1: 9,759 shares were withheld to cover the option cost and applicable taxes.
F2: Employee stock option granted on April 29, 2002 pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 30,000 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,300 Underlying: Common Stock · 30,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 24,303 | $74.76 | $1,816,892.28 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,996 Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 30,000 | $51.30 | $1,539,000.00 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:20 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 79,154 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008521 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,154 Underlying: Common Stock · 79,154 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:31 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,000 | $136.00 | $136,000.00 |
DisclosureSEC source: 0001127602-23-018880 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,299 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 20:17 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,000 | $92.81 | $464,028.50 |
DisclosureSEC source: 0001127602-23-010291 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,299 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.76 to $92.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:15 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 67,141 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008915 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,141 Underlying: Common Stock · 67,141 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 23:44 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerCommon Stock | 5,118 | $96.79 | $495,371.22 |
DisclosureSEC source: 0001127602-22-027489 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 83,500 F1 · kind: The Reporting person disclaims beneficial ownership of the shares held by or disposed of by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owners of the shares held by or disposed of by the trust for purposes of Section 16 or for any other purpose. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 23:44 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerCommon Stock | 382 | $96.60 | $36,901.20 |
DisclosureSEC source: 0001127602-22-027489 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 88,618 F1 · kind: The Reporting person disclaims beneficial ownership of the shares held by or disposed of by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owners of the shares held by or disposed of by the trust for purposes of Section 16 or for any other purpose. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 22:16 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,500 | $93.94 | $328,776.00 |
DisclosureSEC source: 0001127602-22-022564 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,299 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.81 to $94.03. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:11 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-009761 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,650 Underlying: Common Stock · 15,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:11 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 8,650 | $138.85 | $1,201,052.50 |
DisclosureSEC source: 0001127602-22-009761 · form4.xml · nonDerivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,799 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:11 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 15,000 | $41.93 | $628,950.00 |
DisclosureSEC source: 0001127602-22-009761 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:11 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,500 | $138.43 | $346,072.50 |
DisclosureSEC source: 0001127602-22-009761 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,449 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:43 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 125,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008081 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | GiftCommon Stock | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 7 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 89,000 F2 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | GiftCommon Stock | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 6 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,949 F2 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 47,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · derivative · entry 9 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,650 Underlying: Common Stock · 47,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 34,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · derivative · entry 8 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 28,182 | $127.28 | $3,587,004.96 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 5 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,949 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 47,500 | $41.93 | $1,991,675.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 19,349 | $127.24 | $2,462,015.13 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,631 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 34,000 | $39.87 | $1,355,580.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,500 | $127.39 | $318,467.50 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,980 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:11 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 42,347 | $132.09 | $5,593,488.19 |
DisclosureSEC source: 0001127602-21-019252 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,480 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.00 to $132.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| May 14, 2021 Filed May 18, 2021 22:21 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,000 | $142.89 | $714,450.00 |
DisclosureSEC source: 0001127602-21-017260 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,827 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.86 to $142.97. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| May 14, 2021 Filed May 18, 2021 22:21 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 8,030 | $142.85 | $1,147,085.50 |
DisclosureSEC source: 0001127602-21-017260 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,827 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:20 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 174,250 | $0.00 Strike: $122.55 | $0.00 |
DisclosureSEC source: 0001127602-21-009286 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,250 Underlying: Common Stock · 174,250 shares Expires 2031-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:32 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,100 | $120.68 | $374,108.00 |
DisclosureSEC source: 0001127602-21-006762 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,857 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.10 to $121.00. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:32 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 11,900 | $119.73 | $1,424,787.00 |
DisclosureSEC source: 0001127602-21-006762 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,957 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,700 | $102.74 | $174,662.08 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 6 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,857 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.355 to $103.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,192 | $101.69 | $527,970.85 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 5 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,557 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.34 to $102.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 596 | $105.01 | $62,586.97 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,749 Read SEC document |
| November 25, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 136,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · derivative · entry 7 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 136,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 25, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,512 | $105.40 | $264,767.56 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,345 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 25, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 92,194 | $106.14 | $9,785,471.16 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,857 Read SEC document |
| November 25, 2020 Filed Dec 1, 2020 00:31 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 136,000 | $39.87 | $5,422,320.00 |
DisclosureSEC source: 0001127602-20-030141 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:43 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 205,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · derivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · derivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionPSUs (Performance Stock Units) · Derivative | 104,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 104,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. F1 · derivative.expiration_date: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC | CONMED Corp CNMD · Entity 4691 | GrantPSUs (Performance Stock Units) · Derivative | 104,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · derivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires not disclosed F1 · derivative.expiration_date: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 48,903 | $101.68 | $4,972,457.04 |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,801 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 104,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009952 · form4.xml · derivative · entry 5 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009952 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,950 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 200,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009952 · form4.xml · derivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009952 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009952 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 175,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · derivative · entry 7 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2028-03-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.